Back to the main directory
Press Release
- TransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGA by GlobeNewsWire
- Immutep Announces Publication of Abstracts at ESMO Congress 2023 by GlobeNewsWire
- LKQ Corporation Announces Extension of Exchange Offer by GlobeNewsWire
- Daré Bioscience Announces Achievement of First Commercial Milestone Under License Agreement for XACIATO™ (Clindamycin Phosphate) Vaginal Gel, 2%, FDA-Approved Treatment for Bacterial Vaginosis in Females 12 Years or Older by GlobeNewsWire
- Perspective Therapeutics Completes Recruitment for First Patient Cohort in Phase 1/2a Dose Escalation Trial of VMT01 in Malignant Melanoma by GlobeNewsWire
- Ultragenyx Announces Program and Pipeline Updates at Analyst Day Including Interim Data from Ongoing Studies in Osteogenesis Imperfecta (OI), Angelman Syndrome (AS) and Wilson Disease by GlobeNewsWire
- Entera Bio Reports Rapid Pharmacodynamic (PD) Response and Consistent Pharmacokinetic (PK) Data for its First-in-Class Oral PTH(1-34) Mini Tablets at the ASBMR 2023 Annual Meeting by GlobeNewsWire
- Identity and Access Management Solutions Provider BIO-key Sponsors FIDO Alliance’s Authenticate 2023 Conference in Carlsbad, CA, October 16-18, 2023 (Booth #19) by GlobeNewsWire
- Ambrx Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress by GlobeNewsWire
- EQS-News: Mutares has successfully completed the acquisition of the forging business in Germany of CIE Automotive by EQS Group AG
- EQS-News: Francotyp-Postalia Holding AG: Erwerb eigener Aktien – 50. Zwischenmeldung by EQS Group AG
- Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia by GlobeNewsWire
- Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research by BusinessWire
- Alaska Department of Law Selects NICE Justice for Statewide Digital Transformation of Criminal Justice by BusinessWire
- Novo Nordisk A/S – Share repurchase programme by GlobeNewsWire
- Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) Congress by GlobeNewsWire
- Q.E.P. CO., INC. Reports Fiscal 2024 Six Month and Second Quarter Financial Results by GlobeNewsWire
- Flexsteel Industries, Inc. to Announce First Quarter 2024 Results on October 31 by BusinessWire
- Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma by GlobeNewsWire
- Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call by BusinessWire
- Hexatronic AB (publ) inbjuder till telefonkonferens med anledning av delårsrapport Q3, 2023 by GlobeNewsWire
- Global Water Resources Celebrates 20-Years of Providing Award-Winning Total Water Management to Arizona Communities by GlobeNewsWire
- LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration by GlobeNewsWire
- Aprea Unveils Initial Clinical Data on ATRi, ATRN-119, and Pre-Clinical Data on WEE1i, ATRN-1051, at AACR-NCI-EORTC International Conference Supporting Highly Differentiated Synthetic Lethality Portfolio by GlobeNewsWire
- Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures by GlobeNewsWire